197 related articles for article (PubMed ID: 25358405)
1. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X
Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405
[TBL] [Abstract][Full Text] [Related]
2. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
3. The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation.
Hu R; Yang Y; Liu Z; Jiang H; Zhu K; Li J; Xu W
Tumour Biol; 2015 Feb; 36(2):769-77. PubMed ID: 25293521
[TBL] [Abstract][Full Text] [Related]
4. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP.
Siegelin MD; Gaiser T; Siegelin Y
Neurochem Int; 2009 Nov; 55(6):423-30. PubMed ID: 19409438
[TBL] [Abstract][Full Text] [Related]
5. Synergism between NF-kappa B inhibitor, celastrol, and XIAP inhibitor, embelin, in an acute myeloid leukemia cell line, HL-60.
Pazhang Y; Jaliani HZ; Imani M; Dariushnejad H
J Cancer Res Ther; 2016; 12(1):155-60. PubMed ID: 27072230
[TBL] [Abstract][Full Text] [Related]
6. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
[TBL] [Abstract][Full Text] [Related]
8. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.
Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR
Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521
[TBL] [Abstract][Full Text] [Related]
9. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
Kim HS; Chang I; Kim JY; Choi KH; Lee MS
Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
[TBL] [Abstract][Full Text] [Related]
10. X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery.
Zhou J; Lu X; Tan TZ; Chng WJ
Mol Oncol; 2018 Jan; 12(1):33-47. PubMed ID: 29063676
[TBL] [Abstract][Full Text] [Related]
11. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
12. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
Braeuer SJ; Büneker C; Mohr A; Zwacka RM
Mol Cancer Res; 2006 Oct; 4(10):715-28. PubMed ID: 17050666
[TBL] [Abstract][Full Text] [Related]
13. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I
Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836
[TBL] [Abstract][Full Text] [Related]
14. Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells.
Reis-Silva CSM; Branco PC; Lima K; Silva FL; Moreno PRH; Guallar V; Costa-Lotufo LV; Machado-Neto JA
Toxicol In Vitro; 2021 Oct; 76():105207. PubMed ID: 34216723
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
[TBL] [Abstract][Full Text] [Related]
16. Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.
Giaisi M; Köhler R; Fulda S; Krammer PH; Li-Weber M
Int J Cancer; 2012 Aug; 131(4):1003-8. PubMed ID: 21952919
[TBL] [Abstract][Full Text] [Related]
17. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells.
Jiang L; Hao JL; Jin ML; Zhang YG; Wei P
Asian Pac J Cancer Prev; 2013; 14(10):6115-20. PubMed ID: 24289635
[TBL] [Abstract][Full Text] [Related]
18. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.
Lee KY; Park JS; Jee YK; Rosen GD
Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP.
Thayaparasingham B; Kunz A; Peters N; Kulms D
Oncogene; 2009 Jan; 28(3):345-62. PubMed ID: 18978816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
